CrossBridge is developing the most comprehensive, specialty decision-making Software as a Service (SaaS) solution available today for improving outcomes and lowering the cost of treating chronic inflammatory diseases.
Clinical Pathways (CPs) are acknowledged to be an effective multi-disciplinary tool for improving patient outcomes and lowering treatment cost.
CrossBridge now brings CPs to the management of high-cost, inflammatory diseases with our cloud-based, cost-effective SaaS technology combined with a world class Evidence-based Medical Library (EBML) grounded in medical society clinical guidelines.
CrossBridge enables payers, inflammatory disease specialists, and primary care physicians to function as a team better than ever before to improve outcomes and lower costs.
Note: Providers who have developing their own clinical pathways can use their own, as long as they are compliant with medical society guidelines.
CrossBridge was created by value-conscious payers, providers and healthcare technologists to bring about the implementation of Clinical Pathways and usher in a new era in the care of patients with complex, chronic diseases.
Cloud-based system and one-of-a-kind Evidence-based Medical Library (EBML) enable alternative payment models with incentives for consistently achieving better outcomes and cost efficiencies…while rewarding providers to enhance care coordination between primary physician and specialist, leading to improved patient experiences.
CrossBridge is the trusted partner payers and providers can depend on to enter the new era of Value-based Payment for Value-based Care.
From treatment plan selection through reimbursement, the CrossBridge approach is fully aligned with the goal of the Centers for Medicare & Medicaid Services (CMS) and payers – to transition from fee-for-service payment to Alternative Payment Models (APMs)…Value-Based Care (VBC).
VBC demands collaboration between payers and providers to analyze patient/member populations and make shared patient-provider treatment decisions based on actionable data.
The CrossBridge solution make this possible like never before with chronic inflammatory diseases.